163 related articles for article (PubMed ID: 31448698)
1. A computational approach to explore and identify potential herbal inhibitors for the p21-activated kinase 1 (PAK1).
Shahinozzaman M; Ishii T; Ahmed S; Halim MA; Tawata S
J Biomol Struct Dyn; 2020 Aug; 38(12):3514-3526. PubMed ID: 31448698
[TBL] [Abstract][Full Text] [Related]
2. Anti-Inflammatory, Anti-Diabetic, and Anti-Alzheimer's Effects of Prenylated Flavonoids from Okinawa Propolis: An Investigation by Experimental and Computational Studies.
Shahinozzaman M; Taira N; Ishii T; Halim MA; Hossain MA; Tawata S
Molecules; 2018 Sep; 23(10):. PubMed ID: 30262742
[TBL] [Abstract][Full Text] [Related]
3. Precise design of highly isoform-selective p21-activated kinase 4 inhibitors: computational insights into the selectivity mechanism through molecular dynamics simulation and binding free energy calculation.
Su Y; Song P; Wang H; Hu B; Wang J; Cheng MS
J Biomol Struct Dyn; 2020 Aug; 38(13):3825-3837. PubMed ID: 31490101
[TBL] [Abstract][Full Text] [Related]
4. Herbal therapeutics that block the oncogenic kinase PAK1: a practical approach towards PAK1-dependent diseases and longevity.
Maruta H
Phytother Res; 2014 May; 28(5):656-72. PubMed ID: 23943274
[TBL] [Abstract][Full Text] [Related]
5. Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell Culture.
Nguyen BC; Taira N; Maruta H; Tawata S
Phytother Res; 2016 Jan; 30(1):120-7. PubMed ID: 26537230
[TBL] [Abstract][Full Text] [Related]
6. Molecular modelling approaches predicted 1,2,3-triazolyl ester of ketorolac (15K) to be a novel allosteric modulator of the oncogenic kinase PAK1.
Shahinozzaman M; Ahmed S; Emran R; Tawata S
Sci Rep; 2021 Sep; 11(1):17471. PubMed ID: 34471161
[TBL] [Abstract][Full Text] [Related]
7. Several herbal compounds in Okinawa plants directly inhibit the oncogenic/aging kinase PAK1.
Nguyen BC; Taira N; Tawata S
Drug Discov Ther; 2014 Dec; 8(6):238-44. PubMed ID: 25639302
[TBL] [Abstract][Full Text] [Related]
8. Potential target identification for breast cancer and screening of small molecule inhibitors: A bioinformatics approach.
Agarwal S; Kashaw SK
J Biomol Struct Dyn; 2021 Apr; 39(6):1975-1989. PubMed ID: 32186248
[TBL] [Abstract][Full Text] [Related]
9. 1,2,3-Triazolyl esterization of PAK1-blocking propolis ingredients, artepillin C (ARC) and caffeic acid (CA), for boosting their anti-cancer/anti-PAK1 activities along with cell-permeability.
Takahashi H; Nguyen BCQ; Uto Y; Shahinozzaman M; Tawata S; Maruta H
Drug Discov Ther; 2017 May; 11(2):104-109. PubMed ID: 28442677
[TBL] [Abstract][Full Text] [Related]
10. Identification of Pak1 inhibitors using water thermodynamic analysis.
Biswal J; Jayaprakash P; Suresh Kumar R; Venkatraman G; Poopandi S; Rangasamy R; Jeyaraman J
J Biomol Struct Dyn; 2020 Jan; 38(1):13-31. PubMed ID: 30661460
[TBL] [Abstract][Full Text] [Related]
11. Water Mapping and Scoring Approaches to Predict the Role of Hydration Sites in the Binding Affinity of PAK1 Inhibitors.
Biswal J; Jayaprakash P; Rayala SK; Venkatraman G; Rangasamy R; Poopandi S; Jeyakanthan J
Comb Chem High Throughput Screen; 2022; 25(4):660-676. PubMed ID: 33687876
[TBL] [Abstract][Full Text] [Related]
12. A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2.
Islam R; Parves MR; Paul AS; Uddin N; Rahman MS; Mamun AA; Hossain MN; Ali MA; Halim MA
J Biomol Struct Dyn; 2021 Jun; 39(9):3213-3224. PubMed ID: 32340562
[TBL] [Abstract][Full Text] [Related]
13. From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapy.
Maruta H; Ahn MR
Eur J Med Chem; 2017 Dec; 142():229-243. PubMed ID: 28814374
[TBL] [Abstract][Full Text] [Related]
14. Combination of immunoprecipitation (IP)-ATP_Glo kinase assay and melanogenesis for the assessment of potent and safe PAK1-blockers in cell culture.
Nguyen BC; Be Tu PT; Tawata S; Maruta H
Drug Discov Ther; 2015 Aug; 9(4):289-95. PubMed ID: 26370527
[TBL] [Abstract][Full Text] [Related]
15. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
[TBL] [Abstract][Full Text] [Related]
16. Effect of Okinawa Propolis on PAK1 Activity, Caenorhabditis elegans Longevity, Melanogenesis, and Growth of Cancer Cells.
Taira N; Nguyen BC; Be Tu PT; Tawata S
J Agric Food Chem; 2016 Jul; 64(27):5484-9. PubMed ID: 27337169
[TBL] [Abstract][Full Text] [Related]
17. Chemical composition and pharmacological properties of Macaranga-type Pacific propolis: A review.
Shahinozzaman M; Obanda DN; Tawata S
Phytother Res; 2021 Jan; 35(1):207-222. PubMed ID: 32776610
[TBL] [Abstract][Full Text] [Related]
18. Computational insight into the mechanisms of action and selectivity of Afraxis PAK inhibitors.
Han D; Wang H; Cui W; Zhang B; Chen BZ
Future Med Chem; 2020 Mar; 12(5):367-385. PubMed ID: 32064922
[No Abstract] [Full Text] [Related]
19. Frondoside A from sea cucumber and nymphaeols from Okinawa propolis: Natural anti-cancer agents that selectively inhibit PAK1 in vitro.
Nguyen BCQ; Yoshimura K; Kumazawa S; Tawata S; Maruta H
Drug Discov Ther; 2017 May; 11(2):110-114. PubMed ID: 28442678
[TBL] [Abstract][Full Text] [Related]
20. In silico studies on p21-activated kinase 4 inhibitors: comprehensive application of 3D-QSAR analysis, molecular docking, molecular dynamics simulations, and MM-GBSA calculation.
Gao Y; Wang H; Wang J; Cheng M
J Biomol Struct Dyn; 2020 Sep; 38(14):4119-4133. PubMed ID: 31556340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
